Dr. Desai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
49 Spring St
1st Floor
Scarborough, ME 04074Phone+1 207-885-4479Fax+1 207-883-2586
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurological Surgery, 1990 - 1995- New York Presbyterian Hospital (Columbia Campus)Internship, Transitional Year, 1989 - 1990
Columbia University Vagelos College of Physicians and SurgeonsClass of 1989
Certifications & Licensure
ME State Medical License 1998 - 2026
NY State Medical License 1998 - 2000
TX State Medical License 1997 - 2000
ND State Medical License 1995 - 1999- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01
Publications & Presentations
PubMed
- 117 citationsInfluence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized...Martin J.B. Taphoorn, Linda Dirven, Andrew A. Kanner, Gitit Lavy-Shahaf, Uri Weinberg
JAMA Oncology. 2018-04-01 - 836 citationsMaintenance therapy with tumor-Treating fields plus temozolomide vs temozolomide alone for glioblastoma a randomized clinical trialRoger Stupp, S. Taillibert, Andrew A. Kanner, Santosh Kesari, David M. Steinberg
JAMA. 2015-12-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
